Key result
Routinely collected health data identifies inherited heart disease cohorts, primarily Marfan syndrome and HCM.
Why the study?
Can routinely collected health data be used exclusively to identify patients with inherited heart diseases and evaluate their clinical outcomes, resource utilisation, and disease burden?
Systematic Review (n=17,269)
Can routinely collected health data be used exclusively to identify patients with inherited heart diseases and evaluate their clinical outcomes, resource utilisation, and disease burden?
Answers are grounded in this paper and cite their sources.
This systematic review demonstrates that routinely collected administrative and clinical health data can identify patients with inherited heart diseases (primarily Marfan syndrome and hypertrophic cardiomyopathy) to evaluate real-world outcomes and costs, though broader utility is limited by non-specific ICD coding for rare genetic cardiac conditions.
Objective: Our understanding of inherited heart disease is predominantly based on retrospective specialised clinic cohorts, which have inherent selection bias. Population-based routinely collected data can provide insight into unbiased, large-scale patterns of treatment and care but may be limited by the granularity of clinical information available. We sought to synthesise the global literature to determine whether we can identify patients with inherited heart diseases using routinely collected health data. Methods: Medline, Embase, CINAHL, PreMEDLINE and Google Scholar citation databases were searched for relevant articles published between 1 January 2000 and 31 October 2016. Results: A total of 5641 titles/abstracts were screened and 46 full-text articles were retrieved. Twelve peer-reviewed, English-language manuscripts met our inclusion criteria. Studies predominantly focused on Marfan syndrome (41%) or hypertrophic cardiomyopathy (29%). All studies used International Classification of Disease diagnosis codes to define inherited heart disease populations; three studies also used procedure codes. Nine of the 17 definitions for inherited heart disease were repeated across studies. Conclusions: Inherited heart disease populations can be identified using routinely collected health data, though challenges relate to existing diagnosis codes. This is an underutilised resource with the potential to inform patterns of care, patient outcomes and overall disease burden.
No takes yet. Share an insight, caveat, or question.
Blanch et al. (2017) conducted a systematic review in Inherited heart disease (n=17,269). Routinely collected health data (ICD diagnosis and procedure codes) vs. Matched or unmatched control cohorts (reported in 3 of 12 studies, n=7,095,507) was evaluated on Identification of inherited heart disease populations using routinely collected health data and associated outcome themes (resource utilisation, mortality, occurrence of disease, costs, in-hospital interventions). Routinely collected health data identified 17,269 patients with inherited heart disease across 12 studies using 17 ICD code definitions, primarily for Marfan syndrome and HCM.
Synapse has enriched 10 related papers. Consider them for comparative context: